Reduced Amplitude and Velocity in Leprosy pt What is dd
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
leprosy nerve conduction study reduced amplitude AND velocity differential diagnosis axonal demyelinating
Now I have enough information to give a thorough answer. Let me synthesize this carefully.
The key clinical question is: In a leprosy patient, NCS shows both reduced amplitude AND reduced velocity -- what is the differential diagnosis (DD)?
This pattern (both amplitude reduction + velocity slowing) = mixed axonal + demyelinating neuropathy. Here is the complete answer:
NCS in Leprosy: Reduced Amplitude + Reduced Velocity
Understanding the NCS Pattern
| NCS Finding | Primary Pathology |
|---|---|
| Reduced amplitude only | Axonal degeneration (loss of nerve fibers) |
| Reduced velocity only (with normal/near-normal amplitude) | Demyelinating neuropathy |
| Both reduced amplitude AND reduced velocity | Mixed axonal + demyelinating neuropathy |
In leprosy, both patterns coexist, producing the "mixed" picture. This reflects the dual pathologic process in leprosy neuropathy:
- M. leprae invades Schwann cells (which myelinate peripheral nerves) → demyelination → slowed velocity
- Secondary axonal dropout from ischemia, inflammation, and chronic nerve damage → axonal loss → reduced amplitude
Differential Diagnosis (DD) for Reduced Amplitude + Velocity in a Leprosy Patient
1. Leprosy Neuropathy Itself (Most likely - primary diagnosis)
- M. leprae has unique tropism for peripheral nerves, particularly cool-temperature superficial nerves (ulnar, median, posterior tibial, common peroneal, facial, great auricular)
- Causes a mixed axonal + demyelinating polyneuropathy or mononeuropathy multiplex
- NCS abnormalities can precede clinical signs by months
- Sensory parameters affected before motor
- Patterns vary by leprosy type:
- Tuberculoid/borderline leprosy: Mononeuropathy or mononeuritis multiplex (focal nerve involvement)
- Lepromatous leprosy: Diffuse symmetrical length-dependent polyneuropathy (stocking-glove)
2. Leprosy Reaction-Associated Acute Neuritis (Type 1 / Reversal Reaction)
- Acute inflammatory demyelination superimposed on chronic changes
- Further worsens both amplitude and velocity
- Seen in borderline leprosy types (BT, BB, BL) during immune upgrading reactions
3. Drug-Induced Neuropathy (from leprosy treatment)
- Dapsone: Can cause predominantly motor axonal neuropathy (reduces amplitude, may mildly slow velocity)
- Thalidomide (used in ENL reactions): Causes sensory axonal neuropathy
- These can add an axonal component on top of the existing leprosy neuropathy
4. Concurrent/Comorbid Causes (important to exclude)
- Diabetic polyneuropathy - very common co-morbidity; mixed axonal + demyelinating; stocking-glove distribution
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - predominantly demyelinating but amplitude also drops; can mimic or co-exist
- HIV-associated neuropathy - distal sensory axonal neuropathy; HIV is a risk factor in leprosy-endemic populations
- Nutritional deficiency neuropathy (B12, B1, B6 deficiency) - axonal, reduces amplitude; velocity mildly reduced
- Vasculitic neuropathy - mononeuritis multiplex pattern; reduced amplitude + velocity
- Hereditary neuropathy (CMT) - Charcot-Marie-Tooth: CMT1 = demyelinating (very slow velocity), CMT2 = axonal (reduced amplitude); CMT1 has severely reduced velocity with reduced amplitude
Key Distinguishing Points
| Feature | Leprosy Neuropathy | CIDP | Diabetic | CMT1 |
|---|---|---|---|---|
| Pattern | Mononeuritis multiplex OR length-dep. polyneuropathy | Symmetrical demyelinating | Length-dependent | Length-dependent |
| Velocity | Mildly-moderately reduced | Very slow (<38 m/s) | Mildly reduced | Severely reduced (<38 m/s) |
| Amplitude | Reduced | Moderately reduced | Reduced | Reduced |
| Nerve enlargement | Yes (palpable/ultrasound) | Sometimes | No | Yes (hypertrophic) |
| Skin lesions | Yes (hypopigmented, anesthetic) | No | No | No |
| Acid-fast bacilli | Present on skin/nerve biopsy | No | No | No |
| CSF protein | Normal/mildly elevated | Elevated | Normal | Normal |
Summary
In a leprosy patient, reduced amplitude + reduced velocity = mixed axonal + demyelinating neuropathy, most often due to:
- Leprosy neuropathy itself (primary; mixed pattern is characteristic)
- Leprosy reaction (Type 1 reversal reaction) superimposing acute demyelination
- Dapsone toxicity contributing an axonal component
- Concurrent diabetes or nutritional deficiency adding to axonal loss
The cardinal bedside clue differentiating leprosy from other causes is palpably enlarged peripheral nerves (ulnar at elbow, common peroneal at fibular head, great auricular, posterior tibial) + hypopigmented anaesthetic skin patches + confirmed by skin slit smear or nerve/skin biopsy showing AFB.
- Harrison's Principles of Internal Medicine 22E, Chapter 184 (Leprosy section, nerve conduction parameters)
- AAFP: Peripheral Neuropathy Differential Diagnosis (axonal vs. demyelinating NCS interpretation)
- University of Washington Electrodiagnostic Approach (mixed neuropathy NCS patterns)
This is a shared conversation. Sign in to Orris to start your own chat.